COA has a corporate membership for qualified institutional and corporate entities, which include pharmaceutical companies, biotechnology companies, pharmaceutical distributors, and related entities. The nature of this membership is in conformance with all existing laws, regulations, and statues and with the By-laws of COA.
COA has two levels of membership, Basic and Premium.
The Basic Corporate Membership is $75,000 per year, which entitles the contributor to the following benefits:
- Seat on the COA Corporate Board which includes a debriefing by organization on key issues
- COA personnel will speak at meetings and give legislative updates to interested parties as schedules permit
- Corporate sponsor’s name on the COA Web site (www.communityoncology.org)
The Premium Corporate Membership is $250,000 or higher per year and entitles the contributor to basic membership benefits as well as:
- Attendance at various COA meetings held during the year
- Inclusion in special member emails, new COA email Listserv
- COA Practice Information Exchange